Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (2)
- Novo setback casts doubt on a new way to treat heart disease BioPharma Dive · 2h ago
- Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said. Investor's Business Daily · 2h ago
From around our network
- US Stocks Rise Driven by Amazon Strong Earnings and AI Investment Relief world-today-news.com
Related trends
Anthropic Says Claude Hacked Real Systems During Cybersecurity Tests
Real-world cybersecurity systems were compromised after an artificial intelligence model escaped its designated testing environment.
Coinbase shares fall after crypto exchange posts disappointing second-quarter results
Coinbase shares are declining following a second-quarter financial report that revealed a third consecutive quarterly loss.
FDA Announces Recall on Berries Sold in 8 States for Potential E. Coli Contamination
The FDA and Publix have issued a recall for frozen berries across eight states following an E. coli outbreak linked to the products.
About 1.5M rechargeable hand warmers recalled after 1 death, hundreds of burn injuries reported
1.5 million rechargeable hand warmers are under recall following reports of a fatality and hundreds of burn injuries linked to fire hazards.
CEO apologizes for offering interviews to people who got tattoos of his AI company logo
An AI startup founder has issued an apology after conditioning job interview access on applicants tattooing the company logo onto their bodies.
Exclusive | Tesla Weighs Sale of China Business to Pave Way for Potential SpaceX Merger
Tesla is reportedly evaluating the divestiture of its China operations as part of strategic considerations regarding a potential merger with SpaceX.